Clinically validated SmartHealth AI Stations anchor expansion into Clinical-Trial Optimization and Consumer Digital Health, creating multiple recurring-revenue opportunities TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, today outlined a strategic plan to evolve from a single-product health-screening company into a … [Read more…]

– Ocrevus subcutaneous maintains consistent benefit-risk profile after two years – – New late-breaking data confirms Ocrevus significantly reduces disability progression in adults with advanced PPMS – – One-year data reinforce that majority of infants potentially exposed to Ocrevus during pregnancy or breastfeeding exhibit antibody responses – – Fenebrutinib two-year Phase II data demonstrate near-complete … [Read more…]

Galderma will present findings from the ARTIST post-marketing study showing that The Shayping Technique™ – a holistic treatment approach using three Restylane® injectables – significantly enhances facial features and overall appearance, supporting its use to meet diverse patient needs1 Additional presentations will highlight the versatility of Galderma’s aesthetic portfolio in meeting evolving patient and practitioner … [Read more…]

LAKELAND, Fla.–(BUSINESS WIRE)–Following today’s Board of Pharmacy clarification of existing statutes and rules, Publix pharmacies in Florida are now offering the COVID-19 vaccine to eligible individuals 18 years and older. Publix Pharmacy locations outside of Florida are currently administering COVID-19 vaccines according to state guidelines. The U.S. Food and Drug Administration has granted the following … [Read more…]

More Than 20,000 Takeda Employees Across 80 Countries and Regions Voted to Select the FY2025 New Awardees: International Medical Corps (IMC), the Society of Critical Care Medicine (SCCM), the United Nations Office for Project Services (UNOPS) Bangladesh, and Vitamin Angels Takeda’s Four New Collaborations—A Commitment of JPY 4.6 Billion (Approx. USD 32.1 Million)—Boost the Total … [Read more…]

Qatar’s The View Hospital, in affiliation with Cedars-Sinai, earned Gold Awards in Safety and Quality of Care and Continuity of Care & Transition Management The Military Medical City Hospital, managed by EWS, Qatar, received Silver in Sustainability, Innovation & Technology Al Imam Al Hassan Al Mujtaba Teaching Hospital, Iraq, awarded Silver in Safety and Quality … [Read more…]

Anova has launched a global clinical registry to accelerate patient recruitment, speed accrual for sponsors of clinical trials globally AnovaOS® global clinical registry provides a rich source of real-world data to inform clinical decision-making in clinical trials Registry quality data can be used to support post-market surveillance programs, data-driven study design, and marketing approvals The … [Read more…]

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EST on Tuesday, November 4, 2025. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Third Quarter … [Read more…]

Collaboration aims to discover and develop novel small molecule therapeutics against two targets designated by Merck VANCOUVER, British Columbia–(BUSINESS WIRE)–#AIDD—Variational AI, Inc., a generative AI drug discovery company, today announced a collaboration with Merck, known as MSD outside of the United States and Canada, to apply Variational AI’s Enki™ platform to design and optimize novel … [Read more…]

CAMBRIDGE, England–(BUSINESS WIRE)–Healx, the AI-powered biotech company pioneering the next generation of drug discovery for rare diseases, today announced it has entered into a strategic transaction with Vuja De Sciences, a US-based biotech company focused on addressing cancer recurrence and metastatic endurance. Healx’s proprietary AI platform has uncovered and prioritised therapeutic opportunities across rare diseases … [Read more…]